Insider Trading April 1, 2026

Gevo COO Sells 129,797 Shares as Company Posts Strong Revenue Gain but Remains Unprofitable

Transactions executed under a pre-arranged 10b5-1 plan; Gevo reports $161M Q4 2025 revenue and moves to expand ethanol capacity

By Priya Menon GEVO
Gevo COO Sells 129,797 Shares as Company Posts Strong Revenue Gain but Remains Unprofitable
GEVO

Gevo, Inc. President and COO Christopher Michael Ryan sold 129,797 shares across two days under a previously established 10b5-1 plan, reducing but not materially changing his direct stake. The transactions coincided with the stock trading close to its 52-week high, amid a quarter that delivered sharply higher revenue yet continued operating losses. The company is also advancing production and intellectual property initiatives while adjusting senior leadership roles.

Key Points

  • Gevo COO Christopher Michael Ryan sold a total of 129,797 shares on March 30-31, 2026 under a 10b5-1 plan, yielding $363,915 in proceeds.
  • After the sales, Ryan directly owns 1,402,141 shares and indirectly holds 27,888.95 shares through a 401(k) plan.
  • Gevo reported Q4 2025 revenue of $161 million (an 849% year-over-year increase) but recorded a $20 million operating loss; the company plans to expand ethanol capacity and has grown its patent portfolio to over 550 issued and pending patents.

Deal details

Gevo, Inc. (NASDAQ: GEVO) President and Chief Operating Officer Christopher Michael Ryan completed the sale of 129,797 shares of the company's common stock in two sets of transactions at the end of March 2026.

On March 30, 2026, Ryan sold 100,000 shares in multiple trades at prices that ranged from $2.75 to $2.78, producing aggregate proceeds of $275,740. The following day, March 31, he disposed of 29,797 shares at prices between $2.95 and $2.97, generating $88,175 in proceeds.


Context of the trades

The sales were carried out under a pre-arranged 10b5-1 trading plan that Ryan adopted on November 19, 2025. After completing these transactions, Ryan directly holds 1,402,141 shares of Gevo common stock.

In addition to his direct holdings, Ryan indirectly owns 27,888.95 shares through a 401(k) plan. A plan statement dated March 25, 2026, shows that between October 15, 2025, and March 31, 2026, Ryan acquired 5,932.26 shares in the 401(k) and disposed of 51.39 shares to cover administrative fees.


Share price and market context

The stock has been trading near its 52-week high of $2.97, reflecting a roughly 110% gain over the past year. At the time of the report, Gevo shares were quoted at $2.40 and the company had a market capitalization of $565 million.

An InvestingPro analysis cited alongside the filings notes that Gevo remains unprofitable and that analysts do not expect the company to be profitable this year. The same analysis indicates that the stock is trading near its Fair Value assessment.


Recent operating and strategic developments

Gevo posted a notable operational performance in Q4 2025, reporting total revenue of $161 million, an increase of 849% compared with the prior year. Despite that surge in top line, the company recorded a $20 million loss from operations for the quarter, an improvement versus earlier results.

Part of Gevo's revenue mix in 2025 included approximately $5 million from sales of a racing fuel blendstock. That product leverages the company’s proprietary technology to convert renewable feedstocks into high-octane hydrocarbons intended for motorsports applications.

On the production front, Gevo outlined plans to expand its North Dakota site by adding a second ethanol production facility with capacity of up to 75 million gallons per year. If built to full capacity, that addition could potentially increase the site’s annual output to as much as 150 million gallons.

The company has also been strengthening its intellectual property position, reporting a portfolio of more than 550 issued and pending patents related to renewable fuels and chemicals. Those patents are described as covering approaches for producing sustainable aviation fuel and renewable diesel from bio-based feedstocks.


Leadership moves

Gevo announced key executive appointments, naming Kyle James as Chief Commercial Officer and Dave Kettner as General Counsel. The company framed these changes as part of efforts to support commercial growth and governance as it scales production and expands its market footprint.


What this means going forward

The insider sales were executed under an established 10b5-1 plan and left Ryan with a substantial direct and indirect ownership stake. At the same time, the company’s recent quarter shows accelerating revenue alongside ongoing operating losses. Gevo’s operational expansion plans, patent portfolio growth, and new commercial and legal leadership are positioned to support its strategic objectives, while near-term profitability remains an open issue according to third-party analysis.

Risks

  • Gevo remains unprofitable with analysts not expecting profitability this year - a financial risk for equity holders and suppliers.
  • Operational expansion plans, including a second ethanol facility in North Dakota, carry execution and capital deployment risk that could affect the biofuels and industrial supply chains.
  • Insider sales, even under pre-arranged plans, occur while the stock trades near its 52-week high, which may influence market perception of near-term valuation.

More from Insider Trading

Cheniere Energy Executive Disposes $8.7M in Shares; Company Posts Strong Q4 2025 Results Apr 1, 2026 Tesla Director Disposes of $9.27M in Shares, Exercises Options for 40,000 Shares Apr 1, 2026 Monolithic Power Systems EVP Disposes $25.9 Million in Shares Amid Strong Quarterly Results Apr 1, 2026 Beam Therapeutics CEO Completes $1.1M Stock Sales While Increasing Holdings Through Separate Acquisitions Apr 1, 2026 Goodman and Luxor Capital Dispose of $50.5K in Meridian Holdings Shares Apr 1, 2026